Literature DB >> 21988239

CBL mutations in infant acute lymphoblastic leukaemia.

Norio Shiba, Myoung-Ja Park, Tomohiko Taki, Junko Takita, Mitsuteru Hiwatari, Takashi Kanazawa, Manabu Sotomatsu, Eiichi Ishii, Hirokazu Arakawa, Seishi Ogawa, Yasuhide Hayashi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21988239     DOI： 10.1111/j.1365-2141.2011.08900.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

1.  Casitas B-cell lymphoma mutation in childhood T-cell acute lymphoblastic leukemia.

Authors:  Yuka Saito; Yoko Aoki; Hideki Muramatsu; Hideki Makishima; Jaroslaw P Maciejewski; Masue Imaizumi; Takeshi Rikiishi; Yoji Sasahara; Shigeo Kure; Tetsuya Niihori; Shigeru Tsuchiya; Seiji Kojima; Yoichi Matsubara
Journal:  Leuk Res       Date:  2012-05-14       Impact factor: 3.156

Review 2.  The Impact of PI3-kinase/RAS Pathway Cooperating Mutations in the Evolution of KMT2A-rearranged Leukemia.

Authors:  Maria Teresa Esposito
Journal:  Hemasphere       Date:  2019-06-04

Review 3.  Role of CBL Mutations in Cancer and Non-Malignant Phenotype.

Authors:  Davide Leardini; Daria Messelodi; Edoardo Muratore; Francesco Baccelli; Salvatore N Bertuccio; Laura Anselmi; Andrea Pession; Riccardo Masetti
Journal:  Cancers (Basel)       Date:  2022-02-08       Impact factor: 6.639

4.  KMT2A-CBL rearrangements in acute leukemias: clinical characteristics and genetic breakpoints.

Authors:  Alex Bataller; Francesca Guijarro; Aurélie Caye-Eude; Marion Strullu; Arthur Sterin; Oscar Molina; Patrice Chevallier; Marketa Zaliova; Jan Zuna; Pablo Mozas; Laura Magnano; Nathalie Grardel; Pascale Cornillet-Lefebvre; Jen-Fen Fu; Lee-Yung Shih; Temenuzhka Boneva; Elisabeth Nacheva; Silvia Beà; Mònica López-Guerra; Clara Bueno; Pablo Menéndez; Jordi Esteve; Patrizia Larghero; Claus Meyer; Rolf Marschalek
Journal:  Blood Adv       Date:  2021-12-28

Review 5.  Ras/Raf/MEK/ERK Pathway Activation in Childhood Acute Lymphoblastic Leukemia and Its Therapeutic Targeting.

Authors:  Thomas Knight; Julie Anne Elizabeth Irving
Journal:  Front Oncol       Date:  2014-06-24       Impact factor: 6.244
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.